US5656290A
(en)
*
|
1993-02-26 |
1997-08-12 |
The Procter & Gamble Company |
Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
|
US5965161A
(en)
†
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
DE19531277A1
(de)
*
|
1995-08-25 |
1997-02-27 |
Basf Ag |
Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
|
DE19539362A1
(de)
*
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von festen Arzneiformen
|
DE19539360A1
(de)
*
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von festen Arzneiformen
|
FR2748209B1
(fr)
*
|
1996-05-06 |
1998-06-05 |
Adir |
Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs
|
DE19637082A1
(de)
|
1996-09-12 |
1998-03-19 |
Boehringer Mannheim Gmbh |
Schnellzerfallende Pellets
|
US8828432B2
(en)
*
|
1996-10-28 |
2014-09-09 |
General Mills, Inc. |
Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
|
FR2761605B1
(fr)
*
|
1997-04-07 |
2001-02-23 |
Prographarm Lab |
Forme pharmaceutique multiparticulaire, ses particules constitutives, procede et installation pour leur fabrication
|
ATE438305T1
(de)
*
|
1998-03-23 |
2009-08-15 |
Gen Mills Inc |
Verkapselung von komponenten in essbaren produkten
|
DE19842753A1
(de)
|
1998-09-18 |
2000-03-23 |
Bayer Ag |
Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
|
AR024966A1
(es)
|
1999-07-30 |
2002-10-30 |
Smithkline Beecham Plc |
Formulacion farmaceutica
|
DE10045904B4
(de)
*
|
1999-10-01 |
2007-07-12 |
Degussa Gmbh |
alpha-Liponsäure(-Derivate) enthaltende Retardform
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
CN102716101A
(zh)
|
1999-10-29 |
2012-10-10 |
欧罗赛铁克股份有限公司 |
控释氢可酮制剂
|
WO2001034119A2
(en)
*
|
1999-11-12 |
2001-05-17 |
Abbott Laboratories |
Inhibitors of crystallization in a solid dispersion
|
US7364752B1
(en)
|
1999-11-12 |
2008-04-29 |
Abbott Laboratories |
Solid dispersion pharamaceutical formulations
|
US9522217B2
(en)
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
US8088060B2
(en)
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
AU5066101A
(en)
*
|
2000-04-13 |
2001-10-30 |
Synthon B.V. |
Modified release formulations containing a hypnotic agent
|
DE10026698A1
(de)
*
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
|
EP2283829A1
(en)
|
2000-10-30 |
2011-02-16 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
US7883721B2
(en)
|
2001-01-30 |
2011-02-08 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
US7842308B2
(en)
|
2001-01-30 |
2010-11-30 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
GB0102342D0
(en)
|
2001-01-30 |
2001-03-14 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
US6555581B1
(en)
|
2001-02-15 |
2003-04-29 |
Jones Pharma, Inc. |
Levothyroxine compositions and methods
|
US20030198671A1
(en)
*
|
2001-08-10 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique plasma AUC properties
|
DE10150938A1
(de)
*
|
2001-10-04 |
2003-04-24 |
Frunol Delicia Gmbh |
Schädlingsbekämpfungsmittel und Verfahren zu dessen Herstellung
|
US20030180356A1
(en)
*
|
2001-10-29 |
2003-09-25 |
Franz G. Andrew |
Levothyroxine compositions having unique triiodothyronine Tmax properties
|
US7700134B2
(en)
*
|
2002-01-17 |
2010-04-20 |
The Regents Of The University Of Michigan |
Prevention of cisplatin induced deafness
|
US20050182056A9
(en)
*
|
2002-02-21 |
2005-08-18 |
Seth Pawan |
Modified release formulations of at least one form of tramadol
|
US8128957B1
(en)
|
2002-02-21 |
2012-03-06 |
Valeant International (Barbados) Srl |
Modified release compositions of at least one form of tramadol
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
RU2336863C2
(ru)
*
|
2002-06-27 |
2008-10-27 |
Цилаг Аг |
Препараты в виде пеллет сферической формы
|
US7771707B2
(en)
|
2004-06-12 |
2010-08-10 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent drug formulations
|
US10004729B2
(en)
|
2002-07-05 |
2018-06-26 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US8840928B2
(en)
|
2002-07-05 |
2014-09-23 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
WO2004004693A1
(en)
*
|
2002-07-05 |
2004-01-15 |
Collgegium Pharmaceutical |
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
|
AU2003268078A1
(en)
*
|
2002-08-10 |
2004-02-25 |
King Pharmaceuticals, Inc. |
Levothyroxine compositions and methods
|
DE10247037A1
(de)
*
|
2002-10-09 |
2004-04-22 |
Abbott Gmbh & Co. Kg |
Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
|
KR20040043589A
(ko)
*
|
2002-11-19 |
2004-05-24 |
경동제약 주식회사 |
서방성 세파클러 제제 및 그 제조방법
|
SI21353A
(sl)
*
|
2002-11-27 |
2004-06-30 |
Lek farmacevtska družba, d.d. |
Pelete vsebujoče brezvodne tekočine in proces njihove priprave
|
ES2208124B1
(es)
*
|
2002-11-29 |
2005-10-01 |
Laboratorios Del Dr. Esteve, S.A. |
Uso de los compuestos 2,5-dihidroxibencenosulfonicos para la fabricacion de un medicamento.
|
ES2208123A1
(es)
*
|
2002-11-29 |
2004-06-01 |
Laboratorios Del Dr. Esteve, S.A. |
Uso de los compuestos 2,5-dihidroxibencenosulfonicos para la fabricacion de un medicamento.
|
ES2545454T3
(es)
*
|
2002-12-10 |
2015-09-11 |
Nortec Development Associates, Inc. |
Método de preparación de formulaciones biológicamente activas
|
JP2006516969A
(ja)
*
|
2003-01-23 |
2006-07-13 |
アモレパシフィック コーポレーション |
徐放性製剤及びその製造方法
|
US20070059358A1
(en)
*
|
2003-07-02 |
2007-03-15 |
Tianjin Tasly Pharmaceutical Co., Ltd., China |
Matrix adjuvants and the drop pills prepared with them
|
TW200526274A
(en)
|
2003-07-21 |
2005-08-16 |
Smithkline Beecham Plc |
Pharmaceutical formulations
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
US8377952B2
(en)
|
2003-08-28 |
2013-02-19 |
Abbott Laboratories |
Solid pharmaceutical dosage formulation
|
US8025899B2
(en)
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
TWI350762B
(en)
*
|
2004-02-12 |
2011-10-21 |
Euro Celtique Sa |
Particulates
|
GB0403098D0
(en)
*
|
2004-02-12 |
2004-03-17 |
Euro Celtique Sa |
Extrusion
|
TW201240679A
(en)
|
2004-03-12 |
2012-10-16 |
Capsugel Belgium Nv |
Pharmaceutical formulations
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
US20070224281A1
(en)
*
|
2004-07-22 |
2007-09-27 |
Amorepacific Corporation |
Sustained-Release Preparations Containing Topiramate and the Producing Method Thereof
|
EP1834989A1
(en)
*
|
2004-12-27 |
2007-09-19 |
Kaneka Corporation |
Thermoplastic resin composition
|
ATE497995T1
(de)
*
|
2004-12-27 |
2011-02-15 |
Kaneka Corp |
Thermoplastharzzusammensetzung
|
CN101090942A
(zh)
*
|
2004-12-27 |
2007-12-19 |
株式会社钟化 |
热塑性树脂组合物
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US7803413B2
(en)
*
|
2005-10-31 |
2010-09-28 |
General Mills Ip Holdings Ii, Llc. |
Encapsulation of readily oxidizable components
|
US20070184163A1
(en)
*
|
2006-02-07 |
2007-08-09 |
International Flavors, & Fragrances Inc. |
Non-hygroscopic flavor particles
|
WO2007121537A1
(en)
*
|
2006-04-26 |
2007-11-01 |
Alphapharm Pty Ltd |
Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
EP2144599B1
(en)
*
|
2007-03-02 |
2010-08-04 |
Farnam Companies, Inc. |
Sustained release pellets comprising wax-like material
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
JP2011503048A
(ja)
|
2007-11-08 |
2011-01-27 |
グラクソ グループ リミテッド |
医薬製剤
|
CA2710986A1
(en)
*
|
2007-12-29 |
2009-07-16 |
Physics Department M.V. Lomonosov Moscow State University |
Magnetic polymer pellets and a method of generating the blocking gel plug
|
CA2710988A1
(en)
*
|
2007-12-29 |
2009-07-16 |
Physics Department M.V. Lomonosov Moscow State University |
Magnetic polymer pellets and their application methods
|
KR101616246B1
(ko)
|
2008-01-25 |
2016-05-02 |
그뤼넨탈 게엠베하 |
약제학적 투여형
|
KR101094231B1
(ko)
*
|
2008-02-18 |
2011-12-14 |
하나제약 주식회사 |
서방성 고형 제제 및 그의 제조방법
|
MX2010012039A
(es)
|
2008-05-09 |
2010-11-30 |
Gruenenthal Gmbh |
Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio.
|
WO2010011712A1
(en)
*
|
2008-07-22 |
2010-01-28 |
General Mills, Inc. |
Fruit products containing omega-3 fatty acids
|
EP2437616A4
(en)
*
|
2009-06-05 |
2013-08-21 |
Gen Mills Inc |
ENCAPSULATED OMEGA-3 FATTY ACIDS FOR THE MANUFACTURE OF BAKERY PRODUCTS
|
RU2015138422A
(ru)
|
2009-07-22 |
2018-12-25 |
Грюненталь Гмбх |
Стабильная при окислении, прочная на излом лекарственная форма
|
MX2012000317A
(es)
|
2009-07-22 |
2012-02-08 |
Gruenenthal Gmbh |
Forma de dosificacion de liberacion controlada extruida por fusion en caliente.
|
CN106389381A
(zh)
|
2009-12-02 |
2017-02-15 |
阿达玛斯医药公司 |
金刚烷胺组合物及其使用方法
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
WO2011143120A1
(en)
|
2010-05-11 |
2011-11-17 |
Cima Labs Inc. |
Alcoholres i stant metoprolol - containing extended - release oral dosage forms
|
CA2808219C
(en)
|
2010-09-02 |
2019-05-14 |
Gruenenthal Gmbh |
Tamper resistant dosage form comprising inorganic salt
|
ES2487244T3
(es)
|
2010-09-02 |
2014-08-20 |
Grünenthal GmbH |
Forma de dosificación resistente a la manipulación que comprende un polímero aniónico
|
DE102011018403A1
(de)
*
|
2011-04-21 |
2012-10-25 |
Automatik Plastics Machinery Gmbh |
Verfahren zur Herstellung von pharmazeutischen Erzeugnissen aus einem Schmelzematerial
|
CA2839123A1
(en)
|
2011-07-29 |
2013-02-07 |
Grunenthal Gmbh |
Tamper-resistant tablet providing immediate drug release
|
AU2012292418B2
(en)
|
2011-07-29 |
2017-02-16 |
Grunenthal Gmbh |
Tamper-resistant tablet providing immediate drug release
|
MX356421B
(es)
|
2012-02-28 |
2018-05-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
|
CN104394851B
(zh)
|
2012-04-18 |
2017-12-01 |
格吕伦塔尔有限公司 |
抗篡改和抗剂量‑倾泻药物剂型
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
CA2907950A1
(en)
|
2013-05-29 |
2014-12-04 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing one or more particles
|
AR096438A1
(es)
|
2013-05-29 |
2015-12-30 |
Gruenenthal Gmbh |
Forma de dosificación resistente al uso indebido con perfil de liberación bimodal, proceso
|
WO2014204933A1
(en)
|
2013-06-17 |
2014-12-24 |
Adamas Pharmaceuticals, Inc. |
Amantadine compositions and methods of use
|
RU2535049C1
(ru)
*
|
2013-07-11 |
2014-12-10 |
Общество с ограниченной ответственностью "КОМПАНИЯ "ДЕКО" |
Способ получения стабилизированной субстанции дротаверина гидрохлорида
|
BR112016000194A8
(pt)
|
2013-07-12 |
2019-12-31 |
Gruenenthal Gmbh |
forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
|
US20150118300A1
(en)
|
2013-10-31 |
2015-04-30 |
Cima Labs Inc. |
Immediate Release Abuse-Deterrent Granulated Dosage Forms
|
CN105934241B
(zh)
|
2013-11-26 |
2020-06-05 |
格吕伦塔尔有限公司 |
通过低温研磨制备粉末状药物组合物
|
WO2015173195A1
(en)
|
2014-05-12 |
2015-11-19 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
JP2017516789A
(ja)
|
2014-05-26 |
2017-06-22 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
エタノール過量放出に対して防護されている多粒子
|
EP3285745A1
(en)
|
2015-04-24 |
2018-02-28 |
Grünenthal GmbH |
Tamper-resistant dosage form with immediate release and resistance against solvent extraction
|
CA2998259A1
(en)
|
2015-09-10 |
2017-03-16 |
Grunenthal Gmbh |
Protecting oral overdose with abuse deterrent immediate release formulations
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
WO2019040748A1
(en)
|
2017-08-24 |
2019-02-28 |
Adamas Pharma, Llc |
AMANTADINE COMPOSITIONS, THEIR PREPARATION, AND METHODS OF USE
|
EP3965733A4
(en)
|
2019-05-07 |
2023-01-11 |
Clexio Biosciences Ltd. |
ABUSE DETERRENT DOSAGE FORMS CONTAINING ESKETAMINE
|